Vir Biotechnology

#药闻简讯# $Vir Biotechnology(VIR)$ 正在研发一种以安全为首要原则的 T 细胞衔接器 (TCE)，用于治疗转移性去势抵抗性前列腺癌 (MCRPC)。其 I 期临床试验的全面数据将于 2 月底在 ASCO 会议上公布。

#药闻简讯# $Vir Biotechnology(VIR)$ FYI

$腾盛博药-B(02137)$ VIR的丁肝二期数据非常给力，三期在27年一季度出数据，大概率是可以上市的，这也为27年以后腾盛提供了一个现金流产品，保证公司活下去。。。。那时候，自身的乙肝三期数据也差不多快出来了 $Vir Biotechnology(VIR)$

#药闻简讯# $Vir Biotechnology(VIR)$ 授予Norgine在欧洲、澳大利亚和新西兰独家商业化慢性丁型肝炎候选疗法的许可，包括为正在进行的ECLIPSE临床开发项目提供全球成本分摊协议

$Vir Biotechnology(VIR)$ $Janux Therapeutics(JANX)$ 昨天我临阵脱逃了 虽然不多

$Vir Biotechnology(VIR)$ 144 Report of proposed sale of securities Accession Number: 0001493152-25-025052  Act: 33  Size: 15 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-025571  Size: 12 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-025970  Size: 10 KB 网页链接

$Vir Biotechnology(VIR)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001628280-25-057394  Act: 34  Size: 293 KB 网页链接

$Vir Biotechnology(VIR)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001628280-26-001768  Act: 34  Size: 4 MB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-25-025161  Size: 12 KB 网页链接

$Vir Biotechnology(VIR)$ 144 Report of proposed sale of securities Accession Number: 0001959173-25-007063  Act: 33  Size: 4 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-054884  Size: 5 KB 网页链接

$Vir Biotechnology(VIR)$ 144 Report of proposed sale of securities Accession Number: 0001493152-26-002305  Act: 33  Size: 17 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-26-000320  Size: 5 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-25-052841  Size: 5 KB 网页链接

$Vir Biotechnology(VIR)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000060  Act: 33  Size: 6 KB 网页链接

$Vir Biotechnology(VIR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-26-004866  Size: 5 KB 网页链接